Search Result

Results for "

CCL25

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Amyloid-β (1) CCR (6) Small Interfering RNA (siRNA) (3)
By Research Areas:	Endocrinology (4) Inflammation/Immunology (6) Neurological Disease (1)
Oligonucleotides:	Rat Pre-designed siRNA Sets (1) Mouse Pre-designed siRNA Sets (1) Human Pre-designed siRNA Sets (1) siRNAs (3)

Inhibitors & Agonists

Inhibitory Antibodies

Recombinant Proteins

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-123763

MLN3126	CCR	Inflammation/Immunology
MLN3126 is an orally active and potent CCR9 antagonist. MLN3126 inhibits CCL25-induced calcium mobilization and chemotaxis of mouse primary thymocytes, wiht an IC₅₀ value of 6.3 nM for calcium influx .

HY-15724A

Vercirnon sodium 3 Publications Verification GSK-1605786 sodium; CCX282-B sodium; Traficet-EN sodium	CCR	Inflammation/Immunology Endocrinology
Vercirnon (GSK1605786A) sodium is an orally bioavailable, selective, and potent antagonist of CCR9. Vercirnon sodium inhibits CCR9-mediated Ca ²⁺ mobilization and chemotaxis on Molt-4 cells with IC₅₀ values of 5.4 and 3.4 nM, respectively. Vercirnon sodium is selective for CCR9 over CCR1-12 and CX3CR1-7 (IC₅₀s>10 μM for all). Vercirnon sodium is an equipotent inhibitor of CCL25-directed chemotaxis of both splice forms of CCR9 (CCR9A and CCR9B) with IC₅₀ values of 2.8 and 2.6 nM, respectively .

HY-15724

Vercirnon 3 Publications Verification GSK-1605786; CCX282-B; Traficet-EN	CCR	Inflammation/Immunology Endocrinology
Vercirnon (GSK1605786A) is an orally bioavailable, selective, and potent antagonist of CCR9. Vercirnon inhibits CCR9-mediated Ca ²⁺ mobilization and chemotaxis on Molt-4 cells with IC₅₀ values of 5.4 and 3.4 nM, respectively. Vercirnon is selective for CCR9 over CCR1-12 and CX3CR1-7 (IC₅₀s>10 μM for all). Vercirnon is an equipotent inhibitor of CCL25-directed chemotaxis of both splice forms of CCR9 (CCR9A and CCR9B) with IC₅₀ values of 2.8 and 2.6 nM, respectively .

HY-RS02095

CCL25 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
CCL25 Human Pre-designed siRNA Set A contains three designed siRNAs for CCL25 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CCL25 Human Pre-designed siRNA Set A CCL25 Human Pre-designed siRNA Set A

HY-RS17131

Ccl25 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Ccl25 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ccl25 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ccl25 Mouse Pre-designed siRNA Set A Ccl25 Mouse Pre-designed siRNA Set A

HY-RS23576

Ccl25 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Ccl25 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ccl25 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ccl25 Rat Pre-designed siRNA Set A Ccl25 Rat Pre-designed siRNA Set A

HY-P991168

Velaprumig	Amyloid-β CCR	Neurological Disease Inflammation/Immunology
Velaprumig is a monoclonal antibody targeting human CD99, *CCL25, and anti-human Aβ (Aβ-47F*). Velaprumig regulates immune cell migration and reduces β-amyloid-related pathological processes, exerting immunomodulatory and potential anti - Alzheimer's disease activities .

HY-15724R

Vercirnon (Standard)	CCR	Inflammation/Immunology Endocrinology
Vercirnon (Standard) is the analytical standard of Vercirnon. This product is intended for research and analytical applications. Vercirnon (GSK1605786A) is an orally bioavailable, selective, and potent antagonist of CCR9. Vercirnon inhibits CCR9-mediated Ca2+ mobilization and chemotaxis on Molt-4 cells with IC50 values of 5.4 and 3.4 nM, respectively. Vercirnon is selective for CCR9 over CCR1-12 and CX3CR1-7 (IC50s>10 μM for all). Vercirnon is an equipotent inhibitor of CCL25-directed chemotaxis of both splice forms of CCR9 (CCR9A and CCR9B) with IC50 values of 2.8 and 2.6 nM, respectively .

HY-15724AR

Vercirnon sodium (Standard)	CCR	Inflammation/Immunology Endocrinology
Vercirnon (sodium) (Standard) is the analytical standard of Vercirnon (sodium). This product is intended for research and analytical applications. Vercirnon (GSK1605786A) sodium is an orally bioavailable, selective, and potent antagonist of CCR9. Vercirnon sodium inhibits CCR9-mediated Ca2+ mobilization and chemotaxis on Molt-4 cells with IC50 values of 5.4 and 3.4 nM, respectively. Vercirnon sodium is selective for CCR9 over CCR1-12 and CX3CR1-7 (IC50s>10 μM for all). Vercirnon sodium is an equipotent inhibitor of CCL25-directed chemotaxis of both splice forms of CCR9 (CCR9A and CCR9B) with IC50 values of 2.8 and 2.6 nM, respectively .

Cat. No.	Product Name	Target	Research Area

HY-P991168

Velaprumig	Amyloid-β CCR	Neurological Disease Inflammation/Immunology
Velaprumig is a monoclonal antibody targeting human CD99, *CCL25, and anti-human Aβ (Aβ-47F*). Velaprumig regulates immune cell migration and reduces β-amyloid-related pathological processes, exerting immunomodulatory and potential anti - Alzheimer's disease activities .

Recombinant Proteins Recommended:

CCL25

Species:	Human (1) Mouse (1)
Tag:	Tag Free (2)
Source:	E. coli (2)

Cat. No.	Compare	Product Name	Species	Source

HY-P71893

	*TECK/CCL25* Protein, Mouse** CCL25; Scya25; Teck; C-C motif chemokine 25; Chemokine TECK; Small-inducible cytokine A25; Thymus-expressed chemokine	Mouse	E. coli
	The CCL25 protein emerged as a potential coordinator of T cell development, suggesting its involvement in the complex process of T cell maturation. Its recombinant form exhibits chemotactic activity against various immune cell types, including thymocytes and macrophages, by binding to the chemokine receptor CCR9. TECK/CCL25 Protein, Mouse is the recombinant mouse-derived TECK/CCL25 protein, expressed by E. coli , with tag free.

HY-P7294

	*TECK/CCL25* Protein, Human** rHuTECK/CCL25; C-C motif chemokine 25; SCYA25	Human	E. coli
	TECK/CCL25 Protein, Human is a CC chemokine that binds to the chemokine receptor CCR9 and is involved in the development of T cells and cell migration to the small intestine, as well as a variety of inflammatory diseases and promotes inflammatory responses. It has chemotactic effects on thymocytes, macrophages and dendritic cells. TECK/CCL25 Protein, Human is a recombinant human TECK/CCL25(Q24-L150) protein expressed byE. coli.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

CCL25 Human Pre-designed siRNA Set A		siRNAs Human Pre-designed siRNA Sets
CCL25 Human Pre-designed siRNA Set A contains three designed siRNAs for CCL25 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ccl25 Mouse Pre-designed siRNA Set A		siRNAs Mouse Pre-designed siRNA Sets
Ccl25 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ccl25 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ccl25 Rat Pre-designed siRNA Set A		siRNAs Rat Pre-designed siRNA Sets
Ccl25 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ccl25 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Name
Email *

	Sorry, but the email address you supplied was invalid.